These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 38293235)
1. Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking. Johnson EC; Austin-Zimmerman I; Thorpe HH; Levey DF; Baranger DA; Colbert SM; Demontis D; Khokhar JY; Davis LK; Edenberg HJ; Forti MD; Sanchez-Roige S; Gelernter J; Agrawal A medRxiv; 2024 Jan; ():. PubMed ID: 38293235 [TBL] [Abstract][Full Text] [Related]
2. Cross-ancestry genetic investigation of schizophrenia, cannabis use disorder, and tobacco smoking. Johnson EC; Austin-Zimmerman I; Thorpe HHA; Levey DF; Baranger DAA; Colbert SMC; Demontis D; Khokhar JY; Davis LK; Edenberg HJ; Di Forti M; Sanchez-Roige S; Gelernter J; Agrawal A Neuropsychopharmacology; 2024 Jun; ():. PubMed ID: 38906991 [TBL] [Abstract][Full Text] [Related]
3. The relationship between cannabis and schizophrenia: a genetically informed perspective. Johnson EC; Hatoum AS; Deak JD; Polimanti R; Murray RM; Edenberg HJ; Gelernter J; Di Forti M; Agrawal A Addiction; 2021 Nov; 116(11):3227-3234. PubMed ID: 33950550 [TBL] [Abstract][Full Text] [Related]
7. Genetic correlation, pleiotropy, and causal associations between substance use and psychiatric disorder. Jang SK; Saunders G; Liu M; ; Jiang Y; Liu DJ; Vrieze S Psychol Med; 2022 Apr; 52(5):968-978. PubMed ID: 32762793 [TBL] [Abstract][Full Text] [Related]
8. Genetic susceptibility for schizophrenia after adjustment by genetic susceptibility for smoking: implications in identification of risk genes and genetic correlation with related traits. Al-Soufi L; Costas J Psychol Med; 2023 Mar; ():1-11. PubMed ID: 36876478 [TBL] [Abstract][Full Text] [Related]
9. Genetic contribution to the comorbidity between attention-deficit/hyperactivity disorder and substance use disorders. Koller D; Mitjans M; Kouakou M; Friligkou E; Cabrera-Mendoza B; Deak JD; Llonga N; Pathak GA; Stiltner B; Løkhammer S; Levey DF; Zhou H; Hatoum AS; Kember RL; Kranzler HR; Stein MB; Corominas R; Demontis D; Artigas MS; Ramos-Quiroga JA; Gelernter J; Ribasés M; Cormand B; Polimanti R Psychiatry Res; 2024 Mar; 333():115758. PubMed ID: 38335780 [TBL] [Abstract][Full Text] [Related]
10. Is there a shared genetic basis and causal relationship between polycystic ovary syndrome and psychiatric disorders: evidence from a comprehensive genetic analysis. Jiang X; Deng Q; Stener-Victorin E Hum Reprod; 2021 Jul; 36(8):2382-2391. PubMed ID: 34051085 [TBL] [Abstract][Full Text] [Related]
12. Genome-wide association study in individuals of European and African ancestry and multi-trait analysis of opioid use disorder identifies 19 independent genome-wide significant risk loci. Deak JD; Zhou H; Galimberti M; Levey DF; Wendt FR; Sanchez-Roige S; Hatoum AS; Johnson EC; Nunez YZ; Demontis D; Børglum AD; Rajagopal VM; Jennings MV; Kember RL; Justice AC; Edenberg HJ; Agrawal A; Polimanti R; Kranzler HR; Gelernter J Mol Psychiatry; 2022 Oct; 27(10):3970-3979. PubMed ID: 35879402 [TBL] [Abstract][Full Text] [Related]
13. Genome-wide identification of the shared genetic basis of cannabis and cigarette smoking and schizophrenia implicates NCAM1 and neuronal abnormality. Song W; Lin GN; Yu S; Zhao M Psychiatry Res; 2022 Apr; 310():114453. PubMed ID: 35235886 [TBL] [Abstract][Full Text] [Related]
14. Shared genetic links between hypothyroidism and psychiatric disorders: evidence from a comprehensive genetic analysis. Zhou J; Zhu L Front Endocrinol (Lausanne); 2024; 15():1370019. PubMed ID: 38904036 [TBL] [Abstract][Full Text] [Related]
15. Multi-ancestry genome-wide association study of cannabis use disorder yields insight into disease biology and public health implications. Levey DF; Galimberti M; Deak JD; Wendt FR; Bhattacharya A; Koller D; Harrington KM; Quaden R; Johnson EC; Gupta P; Biradar M; Lam M; Cooke M; Rajagopal VM; Empke SLL; Zhou H; Nunez YZ; Kranzler HR; Edenberg HJ; Agrawal A; Smoller JW; Lencz T; Hougaard DM; Børglum AD; Demontis D; ; Gaziano JM; Gandal MJ; Polimanti R; Stein MB; Gelernter J Nat Genet; 2023 Dec; 55(12):2094-2103. PubMed ID: 37985822 [TBL] [Abstract][Full Text] [Related]
17. Using Mendelian randomization to explore the gateway hypothesis: possible causal effects of smoking initiation and alcohol consumption on substance use outcomes. Reed ZE; Wootton RE; Munafò MR Addiction; 2022 Mar; 117(3):741-750. PubMed ID: 34590374 [TBL] [Abstract][Full Text] [Related]
18. Investigation of convergent and divergent genetic influences underlying schizophrenia and alcohol use disorder. Johnson EC; Kapoor M; Hatoum AS; Zhou H; Polimanti R; Wendt FR; Walters RK; Lai D; Kember RL; Hartz S; Meyers JL; Peterson RE; Ripke S; Bigdeli TB; Fanous AH; Pato CN; Pato MT; Goate AM; Kranzler HR; O'Donovan MC; Walters JTR; Gelernter J; Edenberg HJ; Agrawal A Psychol Med; 2023 Mar; 53(4):1196-1204. PubMed ID: 34231451 [TBL] [Abstract][Full Text] [Related]
19. Colocalization of association signals at nicotinic acetylcholine receptor genes between schizophrenia and smoking traits. Al-Soufi L; Costas J Drug Alcohol Depend; 2021 Mar; 220():108517. PubMed ID: 33454625 [TBL] [Abstract][Full Text] [Related]